Published in Medical Letter on the CDC and FDA, June 6th, 2004
"A phase 1 smallpox vaccine trial involving 350 adult volunteers was conducted. Of these subjects, 250 were naive to vaccinia virus vaccine (i.e., 'vaccinia naive'). Volunteers received a new cell-cultured smallpox vaccine or a live vaccinia virus vaccine," scientists in the United States report.
"Nine self-limiting rashes (3.6%) were observed in the vaccinia-naive group," said Richard N. Greenberg and collaborators at the University of Kentucky and DynPort Vaccine Company. "None of the...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.